AR027370A1 - Inmunoensayo y reactivo de diagnostico para malaria, y correspondientes metodos de preparacion, vectores de expresion y transformantes - Google Patents
Inmunoensayo y reactivo de diagnostico para malaria, y correspondientes metodos de preparacion, vectores de expresion y transformantesInfo
- Publication number
- AR027370A1 AR027370A1 ARP010100531A ARP010100531A AR027370A1 AR 027370 A1 AR027370 A1 AR 027370A1 AR P010100531 A ARP010100531 A AR P010100531A AR P010100531 A ARP010100531 A AR P010100531A AR 027370 A1 AR027370 A1 AR 027370A1
- Authority
- AR
- Argentina
- Prior art keywords
- malaria
- surface protein
- diagnosis
- blood
- protozoa
- Prior art date
Links
- 201000004792 malaria Diseases 0.000 title abstract 10
- 239000003153 chemical reaction reagent Substances 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 3
- 239000013604 expression vector Substances 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title 1
- 108010052285 Membrane Proteins Proteins 0.000 abstract 6
- 102000018697 Membrane Proteins Human genes 0.000 abstract 5
- 239000008280 blood Substances 0.000 abstract 3
- 210000004369 blood Anatomy 0.000 abstract 3
- 210000003936 merozoite Anatomy 0.000 abstract 3
- 241000588724 Escherichia coli Species 0.000 abstract 2
- 241000223810 Plasmodium vivax Species 0.000 abstract 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 2
- 238000003018 immunoassay Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000035945 sensitivity Effects 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
- G01N2333/445—Plasmodium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Se provee un inmunoensayo y reactivo de diagnostico para malaria mediante el uso de antígenos de protozoos de malaria que detecta anticuerpos específicosde malaria en sangre al utilizar proteína de superficie de merozoíto de Plasmodium Vivax, present ando alta especificidad y sensibilidad y siendo apropiados enel diagnostico de un tipo de malaria en donde el período latente es prolongado y en donde el numero de protozoos en sangre es bajo. También, se refiere proveerun reactivo de diagnostico e i nmunoensayo para malaria que detecta IgM y/o IgC específicas de malaria en sangre, que puede distinguir pacientes de malaria depersonas normales que se han recuperado completamente de malaria. También se provee un método de preparacion de la proteína de superficie de protozoosmalariales usando levadura o E. Coli, un vector de expresion comprendiendo genes de proteína de superficie de merozoíto de Plasmodium Vivax y residuos dehistidina, como así también transformantes transformados con el vector de expresion. También se provee un método para preparar proteína de superficie demerozoíto de protozoos malariales mediante el uso del transformante. La proteína de superficie de merozoíto de protozoos malariales preparada a partir detransformantes E. Coli o levadura tiene alta sensibilidad, especificidad y pureza. La proteína de superficie preparada tiene senales pseudo-positivasmarcadamente bajas, y es de utilidad en el diagnostico de malaria.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20000007648 | 2000-02-17 | ||
| KR20000007650A KR100482190B1 (ko) | 2000-02-17 | 2000-02-17 | 대장균을 이용한 삼일열 말라리아 원충의 표면 단백질의 제조방법 |
| KR10-2000-0007649A KR100400666B1 (ko) | 2000-02-17 | 2000-02-17 | 효모를 이용한 삼일열 말라리아 원충 표면 단백질의제조방법 |
| KR10-2000-0012172A KR100373918B1 (ko) | 2000-02-17 | 2000-03-10 | 말라리아의 효소 면역학적 측정방법 및 이에 사용되는진단시약 |
| KR10-2000-0045806A KR100427513B1 (ko) | 2000-02-17 | 2000-08-08 | 말라리아 특이 면역글로블린 엠의 검출에 의한 말라리아의면역학적 측정방법, 진단시약 및 진단방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR027370A1 true AR027370A1 (es) | 2003-03-26 |
Family
ID=27532341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010100531A AR027370A1 (es) | 2000-02-17 | 2001-02-06 | Inmunoensayo y reactivo de diagnostico para malaria, y correspondientes metodos de preparacion, vectores de expresion y transformantes |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20040132117A1 (es) |
| EP (1) | EP1255852B9 (es) |
| CN (1) | CN1406284A (es) |
| AR (1) | AR027370A1 (es) |
| AT (1) | ATE417124T1 (es) |
| AU (1) | AU2001236141A1 (es) |
| DE (1) | DE60136911D1 (es) |
| PE (1) | PE20011332A1 (es) |
| WO (1) | WO2001061032A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100373918B1 (ko) * | 2000-02-17 | 2003-02-26 | 주식회사 엘지생명과학 | 말라리아의 효소 면역학적 측정방법 및 이에 사용되는진단시약 |
| KR100427513B1 (ko) * | 2000-02-17 | 2004-04-30 | 주식회사 엘지생명과학 | 말라리아 특이 면역글로블린 엠의 검출에 의한 말라리아의면역학적 측정방법, 진단시약 및 진단방법 |
| DE10161051B4 (de) * | 2001-12-12 | 2005-09-15 | Wieland, Heinrich, Prof. Dr. | Diagnose der Malaria |
| KR101035111B1 (ko) * | 2004-06-30 | 2011-05-19 | 주식회사 엘지생명과학 | 말라리아 플라스모듐 팔시파룸의 면역학적 측정방법 및이에 사용되는 측정 수단 |
| US20080080302A1 (en) * | 2006-09-29 | 2008-04-03 | Fujifilm Corporation | Droplet mixing method and apparatus |
| KR100968848B1 (ko) * | 2007-12-13 | 2010-07-09 | 주식회사 바이오랜드 | 삼일열 및 열대열 말라리아 젖산탈수소효소에 특이적인항체 및 이를 포함하는 열대열 말라리아와 삼일열말라리아의 중복 감염 진단 키트 |
| AP2012006517A0 (en) * | 2010-03-23 | 2012-10-31 | Univ Michigan State | Histidine rich protein-2 diagnostic test for cerebral malaria |
| CN102981002B (zh) * | 2012-11-29 | 2014-08-06 | 同昕生物技术（北京）有限公司 | 采用标签蛋白人源化嵌合抗体作为阳性对照物的间接免疫检测方法及试剂盒 |
| CN103965313B (zh) * | 2013-01-28 | 2016-04-13 | 苏州偲聚生物材料有限公司 | 多肽、包含该多肽的检测器件和检测试剂盒 |
| CN103965324B (zh) * | 2013-01-29 | 2016-08-10 | 苏州偲聚生物材料有限公司 | 多肽、包含该多肽的检测器件和检测试剂盒 |
| CN113406045B (zh) * | 2020-03-16 | 2022-11-04 | 广州创瑞健康科技有限公司 | 一种疟原虫检测的荧光染色方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5304371A (en) * | 1992-02-14 | 1994-04-19 | Lasys Corporation | Peptide for diagnosing and immunizing against T. cruzi infection |
| WO1997026911A1 (en) * | 1996-01-29 | 1997-07-31 | Georgetown University | Malaria vaccine based upon the addition of a msa1 peptide |
| FR2744724B1 (fr) * | 1996-02-14 | 2002-08-02 | Pasteur Institut | Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques |
| DE19723463A1 (de) * | 1997-06-04 | 1998-12-10 | Dade Behring Marburg Gmbh | Immunchemische Bestimmung von multivalenten Analyten |
-
2001
- 2001-02-06 AR ARP010100531A patent/AR027370A1/es not_active Application Discontinuation
- 2001-02-15 AU AU2001236141A patent/AU2001236141A1/en not_active Abandoned
- 2001-02-15 WO PCT/KR2001/000229 patent/WO2001061032A1/en active Application Filing
- 2001-02-15 EP EP01908398A patent/EP1255852B9/en not_active Expired - Lifetime
- 2001-02-15 AT AT01908398T patent/ATE417124T1/de not_active IP Right Cessation
- 2001-02-15 DE DE60136911T patent/DE60136911D1/de not_active Expired - Fee Related
- 2001-02-15 US US10/182,700 patent/US20040132117A1/en not_active Abandoned
- 2001-02-15 CN CN01805160A patent/CN1406284A/zh active Pending
- 2001-02-16 PE PE2001000179A patent/PE20011332A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1406284A (zh) | 2003-03-26 |
| US20040132117A1 (en) | 2004-07-08 |
| AU2001236141A1 (en) | 2001-08-27 |
| WO2001061032A1 (en) | 2001-08-23 |
| ATE417124T1 (de) | 2008-12-15 |
| EP1255852A4 (en) | 2004-12-29 |
| EP1255852B9 (en) | 2009-04-15 |
| EP1255852A1 (en) | 2002-11-13 |
| DE60136911D1 (de) | 2009-01-22 |
| PE20011332A1 (es) | 2002-01-24 |
| EP1255852B1 (en) | 2008-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR027370A1 (es) | Inmunoensayo y reactivo de diagnostico para malaria, y correspondientes metodos de preparacion, vectores de expresion y transformantes | |
| Nickowitz et al. | Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis | |
| ES2064316T3 (es) | Composicion de peptido y procedimiento para la deteccion de anticuerpos frente al htlv-iii. | |
| Nakajima et al. | Bile acids increase intracellular Ca2+ concentration and nitric oxide production in vascular endothelial cells | |
| Ito et al. | ELISA and immunoblot using purified glycoproteins for serodiagnosis of cysticercosisin pigs naturally infected with Taenia solium | |
| Myjak | Efficient production of the Toxoplasma gondii GRA6, p35 and SAG2 recombinant antigens and their applications in the serodiagnosis of toxoplasmosis | |
| BR0211943A (pt) | Anticorpo humano recombinante, molécula de ácido nucléico isolada, célula hospedeira, método para expressar um anticorpo em uma célula hospedeira, método para produzir um anticorpo, uso de um anticorpo humano recombinante, método para diagnóstico da malária, anticorpo humano recombinante purificado, composição, processo de tratamento de uma infecção malárica, método para triar uma coleção de exibição de fago, e, anticorpo | |
| CA1316631C (en) | Protein copolymer malaria vaccine | |
| EP2062913B1 (en) | Toxoplasma GONDII antigens, P35, and uses thereof | |
| Del Giudice et al. | Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria. | |
| US6228372B1 (en) | Compounds and methods for the detection and prevention of T. cruzi infection | |
| CN107003309A (zh) | 用于检测查加斯病的抗原组合物 | |
| ES2366306T3 (es) | Antígeno p30 modificado por ingeniería genética, cóctel de antígenos mejorado y usos de los mismos. | |
| Pinzón et al. | Studies of Plasmodium falciparum rhoptry-associated membrane antigen (RAMA) protein peptides specifically binding to human RBC | |
| Bendezu et al. | Evaluation of Plasmodium falciparum MSP10 and its development as a serological tool for the Peruvian Amazon region | |
| Srivastava et al. | Recombinant polypeptides for serology of malaria | |
| Barnwell | Antigens of Plasmodium vivax blood stage parasites identified by monoclonal antibodies | |
| Alba et al. | Modifying RESA protein peptide 6671 to fit into HLA-DRβ1* pockets induces protection against malaria | |
| Park et al. | Development and evaluation of an immunochromatographic kit for the detection of antibody to Plasmodium vivax infection in South Korea | |
| ASTAGNEAU et al. | Antibodies to the 4-mer repeat of the ring-infected erythrocyte surface antigen (Pf155/RESA) protect against Plasmodium falciparum malaria | |
| Smith et al. | Serum-soluble antigens of malaria: a review | |
| Smedman et al. | Augmented antibody response to live attenuated measles vaccine in children with Plasmodium falciparum parasitaemia | |
| Jakobsen et al. | Isolation and characterization of a soluble antigen complex of Plasmodium falciparum with pyrogenic properties | |
| US20030119053A1 (en) | Antigen cocktails, P35, and uses thereof | |
| Rick et al. | A merozoite-specific 22-kDa rhoptry protein of the coccidium Eimeria nieschulzi (Sporozoa, Coccidia) is exocytosed in the parasitophorous vacuole upon host cell invasion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |